159 related articles for article (PubMed ID: 11940048)
1. Poor uterine development in Turner syndrome with oral oestrogen therapy.
Paterson WF; Hollman AS; Donaldson MD
Clin Endocrinol (Oxf); 2002 Mar; 56(3):359-65. PubMed ID: 11940048
[TBL] [Abstract][Full Text] [Related]
2. Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels.
Bannink EM; van Sassen C; van Buuren S; de Jong FH; Lequin M; Mulder PG; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2009 Feb; 70(2):265-73. PubMed ID: 19200215
[TBL] [Abstract][Full Text] [Related]
3. Uterine Development During Induced Puberty in Girls with Turner Syndrome.
Obara-Moszynska M; Dzialach L; Rabska-Pietrzak B; Niedziela M; Kapczuk K
Front Endocrinol (Lausanne); 2021; 12():707031. PubMed ID: 34295308
[TBL] [Abstract][Full Text] [Related]
4. Pelvic ultrasonography in patients with Turner syndrome: age-related findings in different karyotypes.
Mazzanti L; Cacciari E; Bergamaschi R; Tassinari D; Magnani C; Perri A; Scarano E; Pluchinotta V
J Pediatr; 1997 Jul; 131(1 Pt 1):135-40. PubMed ID: 9255205
[TBL] [Abstract][Full Text] [Related]
5. [Gonadal function in Turner syndrome].
Alves M; Bastos M; Almeida Santos T; Carrilho F
Acta Med Port; 2013; 26(6):655-63. PubMed ID: 24388251
[TBL] [Abstract][Full Text] [Related]
6. Reduced uterine volume after induction of puberty in women with hypogonadism.
Burt E; Davies MC; Yasmin E; Cameron-Pimblett A; Mavrelos D; Talaulikar V; Conway GS
Clin Endocrinol (Oxf); 2019 Dec; 91(6):798-804. PubMed ID: 31487390
[TBL] [Abstract][Full Text] [Related]
7. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
[TBL] [Abstract][Full Text] [Related]
8. A 3-year prospective study to assess uterine growth in girls with Turner's syndrome by pelvic ultrasound.
McDonnell CM; Coleman L; Zacharin MR
Clin Endocrinol (Oxf); 2003 Apr; 58(4):446-50. PubMed ID: 12641627
[TBL] [Abstract][Full Text] [Related]
9. Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial.
Quigley CA; Wan X; Garg S; Kowal K; Cutler GB; Ross JL
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1754-64. PubMed ID: 24762109
[TBL] [Abstract][Full Text] [Related]
10. Gonadotrophin pulsatility in girls with the Turner syndrome: modulation by exogenous sex steroids.
Nathwani NC; Hindmarsh PC; Massarano AA; Brook CG
Clin Endocrinol (Oxf); 1998 Jul; 49(1):107-13. PubMed ID: 9797854
[TBL] [Abstract][Full Text] [Related]
11. The uterine length in women with Turner syndrome reflects the postmenarcheal daily estrogen dose.
Snajderova M; Mardesic T; Lebl J; Gerzova H; Teslik L; Zapletalova J;
Horm Res; 2003; 60(4):198-204. PubMed ID: 14530609
[TBL] [Abstract][Full Text] [Related]
12. Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: results of the German IGLU Follow-up Study 2001.
Doerr HG; Bettendorf M; Hauffa BP; Mehls O; Partsch CJ; Said E; Sander S; Schwarz HP; Stahnke N; Steinkamp H; Ranke MB
Hum Reprod; 2005 May; 20(5):1418-21. PubMed ID: 15695313
[TBL] [Abstract][Full Text] [Related]
13. Current Recommended Estrogen Dosing for Pubertal Induction in Turner Syndrome Results in Normal Uterine Growth.
Lindsay Mart F; Gutmark-Little I; Streich-Tilles T; Trout AT; Khoury J; Bowers K; Casnellie L; Backeljauw P
J Clin Endocrinol Metab; 2024 Feb; 109(3):e1040-e1047. PubMed ID: 37933636
[TBL] [Abstract][Full Text] [Related]
14. The pubertal development mode of Chinese girls with turner syndrome undergoing hormone replacement therapy.
Guo S; Zhang J; Li Y; Ma H; Chen Q; Chen H; Du M
BMC Endocr Disord; 2019 Jul; 19(1):72. PubMed ID: 31296213
[TBL] [Abstract][Full Text] [Related]
15. Individualised vs fixed dose of oral 17β-oestradiol for induction of puberty in girls with Turner syndrome: an open-randomised parallel trial.
Labarta JI; Moreno ML; López-Siguero JP; Luzuriaga C; Rica I; Sánchez-del Pozo J; Gracia-Bouthelier R;
Eur J Endocrinol; 2012 Oct; 167(4):523-9. PubMed ID: 22807477
[TBL] [Abstract][Full Text] [Related]
16. The predictive role of pelvic magnetic resonance in the follow up of spontaneous or induced puberty in turner syndrome.
Maggio MC; De Pietro A; Porcelli P; Serraino F; Angileri T; Di Peri A; Corsello G
Ital J Pediatr; 2018 Feb; 44(1):24. PubMed ID: 29433553
[TBL] [Abstract][Full Text] [Related]
17. Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study.
Nabhan ZM; Dimeglio LA; Qi R; Perkins SM; Eugster EA
J Clin Endocrinol Metab; 2009 Jun; 94(6):2009-14. PubMed ID: 19318455
[TBL] [Abstract][Full Text] [Related]
18. Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment.
Visser JA; Hokken-Koelega AC; Zandwijken GR; Limacher A; Ranke MB; Flück CE
Hum Reprod; 2013 Jul; 28(7):1899-907. PubMed ID: 23539612
[TBL] [Abstract][Full Text] [Related]
19. Use of percutaneous estrogen gel for induction of puberty in girls with Turner syndrome.
Piippo S; Lenko H; Kainulainen P; Sipilä I
J Clin Endocrinol Metab; 2004 Jul; 89(7):3241-7. PubMed ID: 15240598
[TBL] [Abstract][Full Text] [Related]
20. Adrenarche and pubarche in girls with turner syndrome during growth-promoting therapy with human growth hormone.
Dörr HG; Penger T; Marx M; Rauh M; Oppelt PG; Völkl TKM
BMC Endocr Disord; 2019 Jan; 19(1):9. PubMed ID: 30658614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
